compare glp 1 Comparing GLP-type therapies for weight loss in those without diabetes. Two glucagon-like peptide-1 receptor agonists (GLP-1 RAs) (#semaglutide and #liraglutide) and one dual agonist (#tirzepatide) have been FDA-approved for #weightloss in adults Beyond glycemia: Comparing tirzepatide to
Description
Shame is one of the most powerful drivers of eating disorder behavior, and it does not disappear just because a medication is working
doi: 10.1001/jama.2016.10260
Image content: This image is available to view online
Ongoing or severe pain should not be managed at home, as gallbladder complications may require investigation or treatment
Metformin maintains mucosal integrity in experimental model of colitis by inhibiting oxidative stress and pro-inflammatory signaling
Patients considering GLP-1 receptor agonist or dual GIP/GLP-1 receptor agonist therapy should have an open discussion with their healthcare provider about personal and family cancer history
